0022-3417
Monthly
No
1096-9896
J PATHOL
1969
142
ENGLAND
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1096-9896
一般,3-8周審稿時(shí)間
2區(qū)中科院分區(qū)
較難平均錄用比例
5.942影響因子
腫瘤學(xué)小學(xué)科
《病理學(xué)雜志》的主要興趣在于人類疾病的病理生理和發(fā)病機(jī)制,以及這些知識(shí)在診斷和預(yù)后中的應(yīng)用。在確定內(nèi)容時(shí),主要考慮的是卓越的相關(guān)性和新穎性。該雜志歡迎對(duì)人體組織的研究,體外和體內(nèi)的實(shí)驗(yàn)研究,以及基于與人類疾?。òㄞD(zhuǎn)基因系統(tǒng))有明確關(guān)聯(lián)的動(dòng)物模型的研究。研究性和診斷性病理學(xué)的方法改進(jìn)也很有趣。鼓勵(lì)對(duì)病理學(xué)數(shù)據(jù)和臨床結(jié)果進(jìn)行相關(guān)研究,但關(guān)于診斷病理學(xué)的純描述性論文并不被認(rèn)為是該雜志的核心目的。一般來(lái)說(shuō),適當(dāng)采用多種調(diào)查方法的研究比依賴單一方法的研究更為可取。插圖必須具有最高質(zhì)量,才能出版。除了最初的研究論文,該雜志還尋求以各種其他形式提供快速出版,包括社論評(píng)論文章和其他既有貢獻(xiàn)又有索取的特色。如果論文涉及到教學(xué)方法和病理學(xué)實(shí)踐的重大發(fā)展,并且具有國(guó)際范圍和相關(guān)性,則可以接受。如果讀者的信件符合一般利益,將予以公布??傊?,該雜志的目標(biāo)是成為基礎(chǔ)生物醫(yī)學(xué)科學(xué)和臨床醫(yī)學(xué)之間的橋梁。作為大不列顛和愛(ài)爾蘭病理學(xué)會(huì)的一本雜志,它試圖反映該學(xué)會(huì)成員的廣泛科學(xué)利益,但它的精神、作者內(nèi)容和目的是國(guó)際科學(xué)文獻(xiàn)的主要出版物。
http://mc.manuscriptcentral.com/jpath
The main interests of the Journal of Pathology lie in the pathophysiological and pathogenetic mechanisms of human disease and in the application of such knowledge to diagnosis and prognosis. In determining content the primary considerations are excellence relevance and novelty. The Journal welcomes investigative studies on human tissues experimental studies in vitro and in vivo and investigations based on animal models with a clear relevance to human disease including transgenic systems. Methodological improvements in investigative and diagnostic pathology are also of interest. Correlative studies of pathological data and clinical outcomes are encouraged but purely descriptive papers on diagnostic pathology are not considered central to the Journal's purpose. In general studies which appropriately employ multiple investigative techniques are preferred over those which rely on a single methodology. Illustrations must be of the highest quality to be acceptable for publication. As well as original research papers the Journal seeks to provide rapid publication in a variety of other formats including editorials review articles and other features both contributed and solicited. Papers covering significant developments in teaching methods and in the practice of pathology may be acceptable if they are of international scope and relevance. Correspondence from readers will be published if it is of general interest. In summary the Journal aims to serve as a bridge between basic biomedical science and clinical medicine. As a Journal of the Pathological Society of Great Britain and Ireland it seeks to reflect the broad scientific interests of the Society's membership but its ethos authorship content and purpose are those expected of a leading publication in the international scientific literature.
大類學(xué)科 | 分區(qū) | 小類學(xué)科 | 分區(qū) | Top期刊 | 綜述期刊 |
醫(yī)學(xué) | 1區(qū) | PATHOLOGY 病理學(xué) ONCOLOGY 腫瘤學(xué) | 1區(qū) 2區(qū) | 是 | 否 |
JCR分區(qū)等級(jí) | JCR所屬學(xué)科 | 分區(qū) | 影響因子 |
Q1 | ONCOLOGY | Q1 | 9.883 |
PATHOLOGY | Q1 |
CiteScore | SJR | SNIP | 學(xué)科類別 | 分區(qū) | 排名 | 百分位 |
14.10 | 2.537 | 1.865 | 大類:Medicine 小類:Pathology and Forensic Medicine | Q1 | 3 / 193 |
98% |
影響因子 | h-index | Gold OA文章占比 | 研究類文章占比 | OA開(kāi)放訪問(wèn) | 平均審稿速度 |
9.883 | 168 | 38.77% | 82.11% | 未開(kāi)放 | 一般,3-8周 |
快速預(yù)審、投刊前指導(dǎo)、專業(yè)學(xué)術(shù)評(píng)審,對(duì)文章進(jìn)行評(píng)價(jià);
立即咨詢校對(duì)編輯、深度潤(rùn)色,讓稿件符合學(xué)術(shù)規(guī)范,格式體例等標(biāo)準(zhǔn);
立即咨詢適用于語(yǔ)句和結(jié)構(gòu)尚需完善和調(diào)整的中文文章,確保稿件達(dá)到要求;
立即咨詢數(shù)據(jù)庫(kù)包括:期刊、文章、書籍、會(huì)議、預(yù)印書、百科全書和摘要等;
立即咨詢讓作者在期刊選擇時(shí)避免走彎路,縮短稿件被接收的周期;
立即咨詢根據(jù)目標(biāo)期刊格式要求對(duì)作者文章進(jìn)行全面的格式修改和調(diào)整;
立即咨詢幫助作者將稿件提交至目標(biāo)期刊投稿系統(tǒng),降低退稿或拒稿率;
立即咨詢按照您提供的稿件內(nèi)容,指導(dǎo)完成投稿附信(cover letter);
立即咨詢大類學(xué)科同領(lǐng)域優(yōu)質(zhì)期刊 | 大類學(xué)科 | 小類學(xué)科 | 影響因子 | 分區(qū) | ISSN |
---|---|---|---|---|---|
ACTA ONCOLOGICA | 醫(yī)學(xué) | 腫瘤學(xué) | 3.298 | 3區(qū) | 0284-186X |
Advances in Cancer Research | 醫(yī)學(xué) | 腫瘤學(xué) | 4.667 | N/A | 0065-230X |
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 醫(yī)學(xué) | 腫瘤學(xué) | 3.015 | N/A | 0277-3732 |
ANNALS OF ONCOLOGY | 醫(yī)學(xué) | 腫瘤學(xué) | 14.196 | N/A | 0923-7534 |
ANNALS OF SURGICAL ONCOLOGY | 醫(yī)學(xué) | 腫瘤學(xué) | 3.681 | N/A | 1068-9265 |
ANTI-CANCER DRUGS | 醫(yī)學(xué) | 腫瘤學(xué) | 1.801 | N/A | 0959-4973 |
ANTICANCER RESEARCH | 醫(yī)學(xué) | 腫瘤學(xué) | 1.935 | N/A | 0250-7005 |
Asia-Pacific Journal of Clinical Oncology | 醫(yī)學(xué) | 腫瘤學(xué) | 1.539 | N/A | 1743-7555 |
BMC CANCER | 醫(yī)學(xué) | 腫瘤學(xué) | 2.933 | N/A | 1471-2407 |
Brachytherapy | 醫(yī)學(xué) | 腫瘤學(xué) | 2.03 | 4區(qū) | 1538-4721 |
發(fā)現(xiàn)心儀選題請(qǐng)?zhí)顔?/b>
獲取發(fā)表周期短、審稿速度快容易錄用的期刊